A genetic alteration that is already routinely analyzed in patients with acute myeloid leukemia can be used to identify patients who respond to a new targeted therapy, according to a study published ...
Design Therapeutics (NASDAQ:DSGN) outlined its strategy and trial design for DT-216 in Friedreich’s ataxia (FA), emphasizing ...
Trial Design, Dosing and Endpoints David Shapiro, M.D., Appointed to Board of Directors, Strengthening Clinical and Regulatory Expertise Cash and ...
Eli Lilly and Co. is taking another step to bolster its genetic medicine portfolio, this time through a $2.25 billion deal ...
Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...
Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...
This study analyzes BRCA testing patterns in U.S. breast cancer patients, highlighting barriers and disparities in access to genetic testing and precision care.
A genetic alteration that is already routinely analysed in patients with acute myeloid leukaemia can be used to identify ...
The federal government has said Nigeria’s livestock sector is facing a major data gap hindering effective breeding, ...
Insilico Medicine , a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, announced the ...
In the largest study of its kind, researchers showed that birth order can influence conditions such as autism, anxiety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results